10x Genomics, Inc. Accounts Receivable
10x Genomics, Inc. (TXG) had Accounts Receivable of $47.55 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2026-08-07
- 2026-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $47.55M.
- 2026-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $39.03M.
- 2025-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $47.01M.
- 2025-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $43.78M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2026-06-30 | $47.55M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $39.03M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $47.01M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $43.78M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $49.98M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $52.55M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $87.86M 10-K · filed 2026-02-13 |
| 2024-09-30 | $83.53M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $91.18M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $91.31M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $114.83M 10-K · filed 2025-02-13 |
| 2023-09-30 | $103.85M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $87.69M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $77.94M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $104.21M 10-K · filed 2024-02-15 |
| 2022-09-30 | $83.55M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $76.20M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $76.53M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $85.25M 10-K · filed 2023-02-16 |
| 2021-09-30 | $78.43M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $59.68M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $57.41M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $51.21M 10-K · filed 2022-02-18 |
| 2020-09-30 | $36.03M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $22.73M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $30.85M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $33.37M 10-K · filed 2021-02-26 |
| 2019-09-30 | $26.15M 10-Q · filed 2019-11-12 |
| 2018-12-31 | $28.09M 10-K · filed 2020-02-27 |